wrin Flashcards

1
Q

what is neutropenia?

A

reduction in number of neutrophils
ANC <1000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how do you calculate ANC

A

ANC = WBC x (%polys+%bands)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what ANC is high risk and highest risk

A

ANC < 500 high risk
ANC < 100 highest risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

duration of neutropenia putting patients at high risk for infection

A

severe neutropenia > 7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

risk for neutropenia infection

A

increased rate of decline
increased duration
broad spectrum antibiotic use or steroids
stem cell patients and chemo patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

defects in cell mediated immunity impact what

A

primary defense against against intracellular pathogens
T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

defects in humoral immunity impact what

A

primary defense against extracellular pathogens
B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

risk factors for development of infections in immunocompromised patients include

A

neutropenia
immune system defects
destruction of protective barriers
environmental contamination or alteration of flora

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

destruction of skin barrier

A

venipuncture
lines/ports

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

destruction of mucous membranes

A

chemotherapy
radiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

when in hospital, oropharyngeal flora switch to what

A

gram negative bacilii in 48 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

common bacterial pathogens in immunocompromised patients

A

staph aureus
enterococcus
pseudomonas
s. epidermis
streptococci
enterobacterales

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

common fungi pathogens in immunocompromised pathogens

A

candida
aspergilus
zygomycetes
- mucor, rhizopus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

common viruses found in immunocompromised patients

A

herpes simplex virus HSV)
varicella zoster virus (VZV)
cytomegalovirus (CMV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

presentation of infection in neutropenic cancer patients

A

fever >38.3 single oral temp
fever >38 for 1 hour +
- careful because other agents could be causing fever (blood products, chemo, drug fever, malignancy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

issues with etiology documenting in neutropenic cancer patients

A

only microbiologically documented in 30-40% of cases
hard to diagnosie bc we dont have growth in many

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

low risk neutropenic cancer infection considered what

A

neutropenia < 7 days
clinically stable
UTI, uncomplicated cellulitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

high risk neutropenic cancer infection considered what

A

ANC <100 and neutropenia > 7 days
clinically unstable
inpatient, IV

19
Q

empiric regimens for neutropenic cancer patients need what

A

pseudomonas coverage

20
Q

outpatient (low risk treatement) neutropenic infection

A

ciprofloxacin + amox/clav
ciprofloxacin + clindamycin
levofloxacin

21
Q

inpatient neutropenic infection treatment

A

piperacillin/tazobactam
cefepime
imipenem
meropenem
ceftazidime
if penicillin allergy:
- ciprofloxacin + aztreonam + vancomycin

22
Q

targeted therapy for neutropenia infection MRSA

A

vancomycin

23
Q

targeted therapy for neutropenia infection VRE

A

daptomycin
linezolid

24
Q

targeted therapy for neutropenia infection ESBL

A

carbapenem

25
Q

targeted therapy for neutropenia infection KPC

A

meropenem/vaborbactam
imipenem/relebactam
ceftazidime/avibactam

26
Q

targeted therapy for neutropenia infection NDM/IMP/VIM

A

cefiderocol

27
Q

if persistent fever with no documented infection after 4 days of broad spectrum what should we do?

A

anti-fungal therapy

28
Q

anti-fungal therapy

A

amphotericin B
azoles
-fungins

29
Q

if skin or mucosal lesions in febrile neutropenia patients

A

might be viral, evaulate for VZV, HSV

30
Q

HSV treatment

A

acyclovir
valacyclovir

31
Q

CNV treatment

A

ganciclovir
famciclovir

32
Q

most common organisms in catheter related bloodstream infections

A

staph aureus
s. epidermis

33
Q

indications for catheter removal

A

subq tunnel infection
failure to clear blood cultures after 72 hours
persistnet fever
septic embolii
if pathogens present

34
Q

in patients with ANC <500 and uncontrolled primary disease, sepsis, or multiorgan dysfunction what might be helpful?

35
Q

CSF drugs

A

filgrastim
sargramostim

36
Q

do CSFs have benefit in mortality?

37
Q

indications for CSFs

A

prolonged neutropenia and not responding to antimicrobial therapy
ANC < 500
uncontrolled primary disease

38
Q

when can vancomycin be used in initial empiric therapy?

A

hemodynamically unstable
sepsis
pneumonia
gram positive bacteria
line/port infection
SSTI
severe mucositis

39
Q

who should get prophylaxis for infecction in immunocompromised patients?

A

ANC < 100 x 7 days
CML,AML, lymphoma
stem cell transplant
alemtuzumab use

40
Q

prophylaxis treatment for immunocompromised infection

A

ciprofloxacin
levofloxacin
TMP-SMX

41
Q

who should get antifungal prophylaxis?

A

stem cell transplant
induction chemotherapy

42
Q

antifungal prophylaxis

A

azoles
-fungins

43
Q

antiviral prophylaxis used for who

A

HSV positive patients getting stem cell transplant or leukemia induction

44
Q

antiviral prophlaxis drugs

A

acyclovir
annual inactivated flu vaccine
varicella vaccine